Resmed (RMD) Other Accumulated Expenses (2010 - 2021)

Resmed's Other Accumulated Expenses history runs 12 years deep, the most recent figure standing at $12.3 million for Q2 2021.

• Quarterly Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $12.3 million (down 1.77% YoY) and the FY2021 annual result came in at $12.3 million, down 1.77% from the prior year.
• Other Accumulated Expenses was $12.3 million for Q2 2021 at Resmed, down from $12.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12.5 million in Q2 2020 and bottomed at $10.9 million in Q2 2017.
• A 5-year average of $11.6 million and a median of $11.4 million in 2019 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2017 — Other Accumulated Expenses decreased 13.98% — and 2020, when it rose 9.64%.
• Resmed's Other Accumulated Expenses stood at $10.9 million in 2017, then advanced by 0.93% to $11.0 million in 2018, then gained by 3.6% to $11.4 million in 2019, then advanced by 9.64% to $12.5 million in 2020, then declined by 1.77% to $12.3 million in 2021.
• Business Quant data shows RMD's Other Accumulated Expenses at $12.3 million in Q2 2021, $12.5 million in Q2 2020, and $11.4 million in Q2 2019.